MedPath

Effectiveness of Aquatic Theraphy in Spasticity: Watsu and Halliwick

Not Applicable
Conditions
Brain-injury
Registration Number
NCT05151497
Lead Sponsor
University of Cadiz
Brief Summary

Treatment with ACD patients will be carried out through the application of aquatic therapies, being the Halliwick Concept and the Watsu Method together with a time of immersion in hot water.

Detailed Description

The study consists of verifying the efficacy of physiotherapeutic treatment through the use of aquatic therapies, Watsu and Halliwick in subjects who have suffered Acquired Brain Injury (ACD), and who, after that, present spasticity. For this, the users of the Brain Injury Association of Cádiz (ADACCA) are taken as references.

Brain damage is a brain injury, resulting in a series of functional and neurological alterations. The treatment of this pathology will be carried out through the application of aquatic teràpies, being the Halliwick Concept and the Watsu Method.

This study consists of a clinical trial where the experimental group will be applied the combined treatment of Halliwick and Watsu together with a time of immersion in hot water, and to the control group the treatment by Halliwick plus immersion in hot water, in order to evaluate the degree of spasticity they present at the end of the study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Belonging to the Acquired Brain Injury Association of Cádiz
  • Presence of spasticity in the biceps brachii and soleus muscles confirmed by the modified Ashworth Scale and modified Tardieu Scale.
  • Patients who are standing and walking at least with technical assistance and / or supervision.
  • Patients with acquired brain damage and with spastic hemiparesis with a chronic evolution of more than 12 months.
Exclusion Criteria
  • Presence of infections.
  • Other diagnosed diseases that prevent aquatic physiotherapy treatment, such as uncontrolled diabetes or dyspnea at rest.
  • Have received aquatic therapy treatment in the six months prior to the study with the methods developed in the study (Halliwick or Watsu).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Modified TardieuChange from Baseline at 8 weeks

0 (no resistance to movement) to 4 (10 second clonus)

Medical Outcome Study-Sleep ScaleChange from Baseline al 8 weeks

Sleep rating (1 = more trouble falling asleep, a 6 = least trouble sleeping.

Number of years-AgeBaseline

Years

Modified AsworthChange from Baseline at 8 weeks

0 (no increase in muscle tone) to 4 (rigid part in flex-ext)

1 = Left

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Miriam García Blanco

🇪🇸

Cadiz, Cádiz, Spain

Asociación de Daño Cerebral de Cádiz (ADACCA)

🇪🇸

Cadiz, Cádiz, Spain

University of Cadiz

🇪🇸

Cadiz, Spain

© Copyright 2025. All Rights Reserved by MedPath